Form EFFECT 20/20 Biolabs, Inc.
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | April 9, 2026 |
| Accession Number: | 0001213900-26-040545 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 20/20 BioLabs Announces Monthly Investor Webinar Series to be Held on the First Wednesday of Each Month
- FROM STATESIDE TO SILVERSTONE: JIM BEAM® AND THE CADILLAC FORMULA 1® TEAM TOAST TO AMERICA'S 250TH AT THE BRITISH GRAND PRIX
- AARP Invests $237,500 in Quick-Action Projects to Make NY Communities More Livable for All Ages
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
